Step Pharma SAS
- Biotech or pharma, therapeutic R&D
Step Pharma is a clinical stage precision oncology company. Dencatistat (STP938) is a first in class, oral, selective CTPS1 inhibitor currently in Phase I/II clinical development in relapsed/refractory lymphoma, biomarker selected solid tumours and essential thrombocythemia.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}